John G Ullman & Associates Inc Moderna, Inc. Transaction History
John G Ullman & Associates Inc
- $649 Million
- Q3 2024
A detailed history of John G Ullman & Associates Inc transactions in Moderna, Inc. stock. As of the latest transaction made, John G Ullman & Associates Inc holds 49,650 shares of MRNA stock, worth $2.02 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
49,650
Previous 11,250
341.33%
Holding current value
$2.02 Million
Previous $1.34 Million
148.54%
% of portfolio
0.51%
Previous 0.21%
Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
241MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.73 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.64 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.04 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$687 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$295 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...